跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 682 条关于
“STELLAR”
全部
682
临床试验
482
药物
20
机构
29
资讯
151
10个月前
Orbus Therapeutics Reports Positive Phase 3 STELLAR Trial Results for Eflornithine in Recurrent IDH-Mutant Astrocytoma
去年
Eflornithine Plus Lomustine Improves Survival in IDH-Mutant Anaplastic Astrocytoma
去年
Exelixis' Zanzalintinib Shows Promise in Early Trials, Positioning It as Potential Cabozantinib Successor
7天前
FDA Extends Review of Exelixis' Zanzalintinib Plus Tecentriq in Metastatic Colorectal Cancer to March 2027
9个月前
Exelixis and Natera Launch Phase 3 Trial Testing Zanzalintinib in MRD-Positive Colorectal Cancer Patients
去年
Zanzalintinib Plus Atezolizumab Shows Promise in Metastatic Colorectal Cancer
4个月前
Exelixis Partners with Merck for Phase 3 Colorectal Cancer Trial Combining Zanzalintinib with Keytruda
2年前
Sotatercept Approved in Europe for Pulmonary Arterial Hypertension
去年
Eflornithine and Lomustine Combination Shows Survival Benefit in Recurrent Astrocytoma
去年
Exelixis Reports Promising Results for Zanzalintinib Combination in Advanced Kidney Cancer
第 1 页,共 16 页
上一页
下一页